of the lung tissues 4 weeks and 10 weeks after infection to directly ascertain the presence of bacteria ( Figure 6C [2] ). We were able to easily detect the bacilli in Ziehl-Neelsen-stained lung tissues in the case of infection with M. tuberculosis. However, despite extensive screening of tissue sections obtained from all 6 animals infected with the mbtE mutant, we did not observe a single bacterium in the lungs at either time point studied. The absence of bacilli, specifically in the case of infection with the mbtE mutant (as shown by both bacterial enumeration and Ziehl-Neelsen staining of the tissues), is obviously associated with the mutation in mbtE, resulting in the inability of the pathogen to synthesize mycobactins, consequently limiting its replication. The pathology at 4 weeks, observed in the case of infection with the mutant, was the result of limited replication that the pathogen underwent during the early period after infection (before dying due to the unavailability of mycobactins). The pathology at this time point, despite the death of bacteria, could be observed, as tuberculous lesions require more time for resolution. Indeed, no explanation is required for the absence of pathology at 10 weeks: if there were no bacilli even at 4 weeks, the absence of pathology at 10 weeks is only an expected observation.
With regard to the concern expressed by Jones and Niederweis about plating on the supplemented medium, we conclude that the influence of disruption of mycobactin biosynthesis on M. tuberculosis is bactericidal and not bacteriostatic. We draw attention to a study performed by Tullius et al, wherein they observed that rBCG(mbtB)30 (a bacillus CalmetteGuerin strain in which mbtB has been deleted) could undergo only a limited replication in guinea pigs until 3 weeks, because of disruption of mycobactin biosynthesis, and no colonies were observed despite plating on the medium containing mycobactins [3] . Moreover, in a separate in vitro study, we observed that the effect of disruption of mycobactin biosynthesis on M. tuberculosis is bactericidal. In this study, the mbtE mutant grew to an A 600nm of 0.3, and replication declined thereafter. After this, no bacteria could be revived from this culture, even after mycobactin supplementation, which clearly demonstrates that the loss of mycobactins is bactericidal.
Apart from these explanations, which amply demonstrate the importance of the enzymes of mycobactin biosynthesis in virulence and as novel targets for the development of antituberculosis drugs, many other investigators have reached similar conclusions [4] [5] [6] [7] [8] [9] [10] . Here are 2 examples in brief: (1) De Voss et al demonstrated that mbtB gene deletion (which disrupts siderophore biosynthesis) renders the resulting mutant impaired for growth in THP-1 macrophages, implying that the siderophore production is important for the virulence of M. tuberculosis [4] ; and (2) the bisubstrate inhibitors of MbtA (a salicylation enzyme required for siderophore biosynthesis) inhibits the growth of M. tuberculosis, with an 99% minimum inhibitory concentration of 0.049 μM, demonstrating that the enzymes of mycobactin biosynthesis can act as novel targets for the development of therapeutic interventions against mycobacterial infections [5, 10] .
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